biologic medicines

Market Access

China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline.

News

At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.